Status:
UNKNOWN
The Effectiveness of a Thyme and Honey Spray for Oral Toxicities
Lead Sponsor:
Cyprus University of Technology
Collaborating Sponsors:
German Oncology Center, Cyprus
Bank of Cyprus Oncology Center BOCOC
Conditions:
Cancer of the Head and Neck
Xerostomia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aim: To evaluate the effectiveness of thymus honey on radiation induced-oral mucositis and xerostomia. Background: Oral mucositis and xerostomia are two of the most severe side effects that head and ...
Eligibility Criteria
Inclusion
- Patients with a confirmed histologic diagnosis of head and neck cancer
- Patients referred to non-palliative radiotherapy to the oral cavity will be included in the study
- Synchronous or induction chemotherapy, or both, will be permitted.
- Patients aged over 18,
- Patients able to provide informed consent,
- Patients having radiotherapy for at least three weeks (lower limit has been set at 50 Gy),
- Patients able to complete records accurately
Exclusion
- Patients with a confirmed and medically treated diabetes mellitus,
- Patients with allergy to honey, thyme or any other ingredient,
- Patients who will refuse to take part in this study and
- Patients with previous radiotherapy or presence of systemic disease.
Key Trial Info
Start Date :
November 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04880148
Start Date
November 3 2021
End Date
September 1 2024
Last Update
December 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
German Oncology Center
Limassol, Cyprus, 4108
2
Bank of Cyprus Oncology Center
Nicosia, Cyprus, 2006